In this MR analysis of up to 287,829 cases and 606,790 controls, we found weak evidence for an association of genetically proxied PPARG perturbation with a higher risk of prostate cancer and lower risk of ER+ breast cancer. This evidence concerns the gene PPARG and prostate carcinoma.